Hare KJ, Vilsboll T, Asmar M, Deacon CF, Knop FK, Holst JJ (2010) The glucagonostatic and insulinotropic effects of glucagon-like peptide 1 contribute equally to its glucose-lowering action
While some providers may see microdosing as a way to ease patients into treatment or reduce side effects, others worry about its risks
Some people notice their first measurable weight changes
What Are Retatrutide and Tirzepatide
Rather than simply prescribing medication, our providers help patients navigate the entire weight loss process
Our patient Daniel (33 years old, 280 lbs, 10 years with psoriasis and PsA) saw dramatic improvements with GLP-1 therapyweight loss, reduced pain and swelling, healthier skin, and a reduced need for medications after 6 months